Tag: Prescription Drugs
ACC: Bempedoic Acid Cuts Cardiovascular Event Risk in Statin-Intolerant
Those receiving bempedoic acid had greater reduction in LDL cholesterol and significantly lower incidence of composite of major adverse cardiovascular events
Magnitude of Reduction in PSA Level May Indicate Outcomes in Prostate Cancer
Findings seen for men treated with enzalutamide for nonmetastatic castration-resistant prostate cancer
Clinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
Significant reductions seen in weight, HbA1c, total daily dose of insulin with GLP-1RA, and in HbA1c and basal insulin with SGLTi
No Consistent Link Found Between β-Blockers, Psychiatric Outcomes
Periods of β-blocker treatment linked to reduced risk for psychiatric hospitalization, increased risks for suicidal behavior
Texas Judge Set to Rule on Abortion Pill
Lawsuit seeks to reverse U.S. Food and Drug Administration approval of the medication mifepristone
Most U.S. Adults With T2DM Meet Criteria for GLP-RAs, SGLT2is
82.3 percent of U.S. adults with type 2 diabetes meet recommended criteria for use; 9.1 percent used either of them
Eight-Week Bedaquiline-Linezolid Noninferior for TB
Eight-week treatment noninferior to standard regimen for composite of death, ongoing treatment, active disease at week 96
Feds Will Start Limiting Telehealth Prescriptions for Painkillers, ADHD Drugs
Patients will be required to see a doctor in person to get a first prescription for opioids, ADHD drugs
ADHD Med Exposure in Utero Not Tied to Long-Term Impact in Offspring
No signs of higher risk seen for developmental disorders
U.S. to Allow Medicaid to Pay for Drug Treatment in Prisons
By summer, all federal prisons will offer medications to treat substance use disorder
